![]() |
市場調查報告書
商品編碼
1961339
層析法市場-全球產業規模、佔有率、趨勢、機會、預測:按類型、最終用戶、地區和競爭格局分類,2021-2031年Chromatography Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By End User, By Region & Competition, 2021-2031F |
||||||
全球層析法市場預計將從 2025 年的 100.3 億美元大幅成長至 2031 年的 136.9 億美元,複合年成長率為 5.32%。
層析法仍然是分離複雜混合物中特定成分並進行精確鑑定和純化的基礎分析技術。推動這一成長的主要因素是製藥和生物技術產業研發活動的廣泛擴展,這些活動需要嚴格的測試通訊協定來進行藥物發現和品質保證。此外,政府對食品安全分析和環境監測的嚴格監管也迫使實驗室採用可靠的分離技術。根據歐洲製藥工業協會聯合會 (EFPIA) 的報告,預計到 2024 年,歐洲製藥業將在研發方面投入約 550 億歐元,這凸顯了巨額投資對先進分析儀器的需求。
| 市場概覽 | |
|---|---|
| 預測期 | 2027-2031 |
| 市場規模:2025年 | 100.3億美元 |
| 市場規模:2031年 | 136.9億美元 |
| 複合年成長率:2026-2031年 | 5.32% |
| 成長最快的細分市場 | 液相層析法 |
| 最大的市場 | 北美洲 |
儘管有這些正面因素,但由於先進層析法系統需要大量資本投入,市場仍面臨許多障礙。購置和維護高性能設備的高昂成本往往超出小規模合約研究機構和學術組織的財力。這種經濟壁壘阻礙了這些技術的廣泛應用,也是資源匱乏地區市場擴張的主要障礙。因此,儘管對先進分析技術的需求依然旺盛,但高昂的進入門檻仍然限制著小規模機構更廣泛地獲取和應用這些技術。
製藥和生物技術產業研發投入的成長是全球層析法市場的主要驅動力,尤其是在該行業向複雜生物療法轉型之際。隨著各機構專注於開發單株抗體、生物相似藥和個人化療法,對高解析度分離技術的需求顯著增加,以確保藥物純度和符合監管要求。這項轉變的特徵是藥物研發管線的大量投資,這些管線大量採用液相層析法和質譜技術進行表徵。例如,默克在2024年2月的財務報告中揭露,其2023年全年研發支出達到305億美元。這代表著對臨床專案投資的策略性擴張,直接推動了用於高通量篩檢和品管的先進設備的採購。
同時,嚴格的食品安全和品管標準的實施,要求實驗室具備更強的污染物和農藥殘留檢測能力。隨著世界各國政府不斷降低可接受的限值,高靈敏度的層析法解決方案對於確保合規性和保護消費者至關重要。美國食品藥物管理局(FDA) 在 2024 年 3 月發布的 2025 會計年度總結報告中宣布,已特別申請額外 1,500 萬美元用於食源性疾病預防基礎設施的現代化改造,凸顯了聯邦政府致力於提升檢測能力的決心。這種法規環境為主要設備製造商提供了穩定的收入來源。例如,安捷倫科技公司 (Agilent Technologies) 2023 年 11 月公佈的年銷售額為 68.3 億美元,這表明在這些關鍵分析需求的驅動下,該行業擁有巨大的經濟規模。
購置和維護先進層析法系統所需的大量資本投入是限制全球層析法市場擴張的主要障礙。中小企業,尤其是受託研究機構和學術實驗室,往往面臨嚴格的預算限制,使得引進高效液相層析法(HPLC)和氣相層析法(GC)設備在經濟上難以承受。這種成本壁壘限制了最尖端科技的應用,使其主要局限於資金雄厚的製藥公司,從而限制了潛在基本客群,並阻礙了在經濟敏感地區的市場滲透。
這些財務限制也反映在近期的產業績效數據中,數據顯示企業不願採購大規模設備。德國工業協會Spectalis在2024年發布的報告顯示,分析、生物和實驗室技術領域的國內銷售額下降了0.1%,至52.2億歐元,主要客戶行業的投資放緩被認為是造成市場停滯的原因。這一事實凸顯了經濟謹慎和營運成本飆升如何直接限制了必要分析設備的採購,阻礙了市場實現最大成長。
隨著實驗室努力遵守國際永續性指南並減少對環境的影響,向綠色層析法和永續溶劑的轉型正迅速成為至關重要的趨勢。這一趨勢包括引入節能設備,旨在用環保替代品取代有害的有機溶劑,並減少廢棄物產生。製造商正積極響應這項需求,開發出能夠顯著降低能源和溶劑消耗,同時保持卓越分析能力的系統。例如,沃特世公司在其2024年12月發布的《環境、社會和管治報告》中宣布,與2016年相比,其範圍1和範圍2的溫室氣體排放減少了36%,這表明這些永續戰略已在行業內實用化。
同時,人工智慧(AI)在方法最佳化領域的應用正透過自動化複雜的決策任務和提高數據準確性,徹底改變市場格局。實驗室擴大使用AI驅動的軟體來自主調整分離參數、合併峰值以及預測儀器維護需求,從而有效消除了人工數據解讀帶來的瓶頸。這項技術進步不僅提升了處理能力,還確保了研究工作流程中更高的品管和可重複性。根據島津公司截至2024年11月的會計年度財務報告,該公司獲得了總額達1,300億日圓的訂單。這項業績主要得益於其成功推出了一款配備AI驅動的自動化波形處理功能的新型液相層析法系統。
The Global Chromatography Market is projected to expand significantly, rising from a valuation of USD 10.03 Billion in 2025 to USD 13.69 Billion by 2031, reflecting a compound annual growth rate of 5.32%. Chromatography remains a cornerstone analytical method used to isolate specific components within complex mixtures for accurate identification and purification. A major catalyst for this growth is the extensive broadening of research and development initiatives within the pharmaceutical and biotechnology industries, which demand stringent testing protocols for drug discovery and quality assurance. Furthermore, rigorous government mandates regarding food safety analysis and environmental monitoring are compelling laboratories to acquire dependable separation technologies. As reported by the European Federation of Pharmaceutical Industries and Associations, the pharmaceutical sector in Europe invested approximately €55,000 million in R&D during 2024, highlighting the immense financial commitment that underpins the demand for sophisticated analytical equipment.
| Market Overview | |
|---|---|
| Forecast Period | 2027-2031 |
| Market Size 2025 | USD 10.03 Billion |
| Market Size 2031 | USD 13.69 Billion |
| CAGR 2026-2031 | 5.32% |
| Fastest Growing Segment | Liquid Chromatography |
| Largest Market | North America |
Despite these positive indicators, the market confronts substantial obstacles due to the steep capital expenditures necessary for advanced chromatographic systems. The significant expense of acquiring and maintaining high-performance instruments often surpasses the financial capabilities of smaller contract research organizations and academic institutions. This economic hurdle impedes the widespread integration of these technologies and acts as a significant barrier to market expansion in regions with limited resources. Consequently, while the demand for advanced analytics is high, the financial burden of entry continues to restrict broader accessibility and adoption across smaller entities.
Market Driver
Escalating expenditure on research and development within the pharmaceutical and biotechnology sectors serves as a dominant engine for the global chromatography market, specifically as the industry pivots toward complex biological therapeutics. As organizations intensify their focus on developing monoclonal antibodies, biosimilars, and personalized treatments, the requirement for high-resolution separation methods to guarantee purity and regulatory adherence has grown substantially. This shift is defined by significant capital investment in discovery pipelines that depend heavily on liquid chromatography and mass spectrometry for characterization. For example, Merck & Co. revealed in its February 2024 financial report that research and development expenses hit $30.5 billion for the full year of 2023, signaling a strategic boost in clinical programs that directly drives the procurement of advanced instrumentation for high-throughput screening and quality control.
Concurrently, the enforcement of rigorous food safety and quality control standards is necessitating that laboratories enhance their ability to detect contaminants and pesticide residues. Governments around the globe are lowering permissible limits, requiring highly sensitive chromatographic solutions to ensure compliance and protect consumers. According to the U.S. Food and Drug Administration's March 2024 budget summary for Fiscal Year 2025, the agency requested a $15 million increase specifically to modernize its infrastructure for preventing foodborne illness, emphasizing a federal commitment to better testing capabilities. This regulatory environment creates a reliable revenue stream for leading instrument providers, as evidenced by Agilent Technologies, which reported full-year revenue of $6.83 billion in November 2023, demonstrating the vast financial scale of the sector supported by these critical analytical needs.
Market Challenge
The substantial capital investment required to purchase and sustain advanced chromatographic systems acts as a major impediment to the expansion of the global chromatography market. Small and medium-sized enterprises, specifically contract research organizations and academic laboratories, frequently face strict budgetary limitations that render the acquisition of high-performance liquid chromatography or gas chromatography instruments financially impractical. This cost-related obstacle confines the utilization of cutting-edge technology primarily to well-resourced pharmaceutical corporations, thereby restricting the potential client base and hindering market penetration in economically sensitive regions.
The consequence of these financial constraints is visible in recent industry performance data, which indicates a reluctance to commit to large-scale equipment acquisitions. As reported by the German industry association Spectaris in 2024, domestic sales for the analytical, bio, and laboratory technology sector fell by 0.1% to €5.22 billion, a stagnation blamed on hesitant investment trends among key customer industries. This evidence highlights how economic prudence and elevated operational expenses are directly limiting the procurement of necessary analytical instrumentation, keeping the market from achieving its maximum growth trajectory.
Market Trends
The transition toward Green Chromatography and Sustainable Solvents is quickly becoming a pivotal trend as laboratories strive to comply with international sustainability directives and decrease their environmental impact. This movement entails substituting toxic organic solvents with environmentally friendly alternatives and deploying energy-efficient equipment engineered to reduce waste production. Manufacturers are addressing this demand by developing systems that preserve superior analytical capabilities while substantially cutting down on energy and solvent consumption. For instance, Waters Corporation noted in its December 2024 Environmental, Social, and Governance Report that it achieved a 36% decrease in Scope 1 and Scope 2 greenhouse gas emissions compared to 2016, demonstrating the real-world application of these sustainable strategies within the industry.
Simultaneously, the incorporation of Artificial Intelligence for Method Optimization is revolutionizing the market by automating intricate decision-making tasks and improving data precision. Laboratories are increasingly utilizing AI-powered software to autonomously refine separation parameters, integrate peaks, and forecast instrument maintenance requirements, effectively eliminating bottlenecks linked to manual data interpretation. This technological evolution not only boosts throughput but also guarantees greater reproducibility in quality control and research workflows. According to Shimadzu's financial results from November 2024, the company secured orders totaling 130.0 billion yen, a performance largely underpinned by the successful launch of new liquid chromatography systems featuring AI-automated waveform processing capabilities.
Report Scope
In this report, the Global Chromatography Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Chromatography Market.
Global Chromatography Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: